Keep CEOs on short leash during GMP inspections, experts say
When FDA comes for a GMP inspection, it’s best for your CEO to be mostly seen and not heard, an industry panel agreed recently.
Archives for September 16, 2012
Size matters: Researchers warn nano-polyphenols may have reversed effects
The beneficial effects attributed to antioxidants such as polyphenols could be reversed when they are used in nano-forms, according to new research.
GMPs: Lack of records starting to sound like broken record
Lack of good record keeping forms the lion’s share of mentions on the warning letters companies receive from FDA after a GMP inspection, a consultant said in an industry meeting recently.